Formation Of Biotech Panel Reflects PCAST's Fresh Look

WASHINGTON - Life scientists on the President's Council of Advisers for Science and Technology won their first skirmish last month in an ongoing campaign to prod PCAST into the 1990s. The issue that arose during the council's second public meeting was the question of whether PCAST should create its own advisory group on biotechnology. Presidential science adviser Allan Bromley, who also is director of the White House Office of Science and Technology Policy, asked the council whether it wanted

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON - Life scientists on the President's Council of Advisers for Science and Technology won their first skirmish last month in an ongoing campaign to prod PCAST into the 1990s.

The issue that arose during the council's second public meeting was the question of whether PCAST should create its own advisory group on biotechnology.

Presidential science adviser Allan Bromley, who also is director of the White House Office of Science and Technology Policy, asked the council whether it wanted to form such a group after it had heard associate director James Wyn-gaarden outline the growing importance of biotechnology in the national research effort. PCAST has already agreed to set up similar groups of outside experts in high-performance computing, and it is planning other panels on such topics as materials science and science and mathematics education.

PCAST voted yes despite comments from Bromley that it would "use up our most precious ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies